Matthew Ferguson
Known title: CHIEF FINANCIAL OFFICERCIK: 0001304079
Matthew Ferguson's purchase track record
How the stock did after each of Matthew Ferguson's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since December 2, 2022
Stock higher 6 months later
67%
3 months: 100%
Median 6-month return
+61.6%
3 months: +73.8%
Beat the S&P 500
67%
median +50.0% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/17/2025 | ELUT | $32K | +113.9% | +96.2% | +10.4% |
| 12/1/2025 | ELUT | $7K | +73.8% | +61.6% | +11.6% |
| 12/2/2022 | ELUT | $126K | +1.5% | -42.8% | +5.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ELUT | ▲ Buy | Option Exercise | 12,500 | — | 9/10/2026 | View on chart |
| ELUT | ▼ Sell | Tax Withholding | 4,486 | $4K | 9/10/2026 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 12,500 | — | 6/10/2026 | View on chart |
| ELUT | ▼ Sell | Tax Withholding | 4,485 | $5K | 6/10/2026 | View on chart |
| ELUT | ▼ Sell | Tax Withholding | 5,123 | $6K | 3/10/2026 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 12,500 | — | 3/10/2026 | View on chart |
| ELUT | ▲ Buy | Open Market | 60,000 | $32K | 12/17/2025 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 12,500 | — | 12/10/2025 | View on chart |
| ELUT | ▼ Sell | Tax Withholding | 4,461 | $3K | 12/10/2025 | View on chart |
| ELUT | ▲ Buy | Open Market | 5,500 | $4K | 12/2/2025 | View on chart |
| ELUT | ▲ Buy | Open Market | 4,500 | $3K | 12/1/2025 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 29,000 | — | 9/10/2025 | View on chart |
| ELUT | ▼ Sell | Tax Withholding | 10,348 | $14K | 9/10/2025 | View on chart |
| ELUT | ▼ Sell | Tax Withholding | 4,461 | $9K | 6/10/2025 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 12,500 | — | 6/10/2025 | View on chart |
| ELUT | ▼ Sell | Tax Withholding | 528 | $1K | 3/10/2025 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 29,000 | — | 3/10/2025 | View on chart |
| ELUT | ▼ Sell | Tax Withholding | 11,885 | $36K | 3/10/2025 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 1,287 | — | 3/8/2025 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 12,500 | — | 12/10/2024 | View on chart |
| ELUT | ▼ Sell | Tax Withholding | 4,461 | $19K | 12/10/2024 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 29,500 | — | 9/10/2024 | View on chart |
| ELUT | ▼ Sell | Tax Withholding | 10,527 | $44K | 9/10/2024 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 50,000 | — | 8/12/2024 | View on chart |
| ELUT | ▼ Sell | Tax Withholding | 17,840 | $51K | 8/12/2024 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 105,080 | $150K | 7/31/2024 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 25,000 | — | 6/10/2024 | View on chart |
| ELUT | ▼ Sell | Tax Withholding | 8,920 | $31K | 6/10/2024 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 1,288 | $0 | 3/8/2024 | View on chart |
| ELUT | ▼ Sell | Tax Withholding | 528 | $2K | 3/8/2024 | View on chart |
| ELUT | ▲ Buy | Grant | 70,053 | — | 9/21/2023 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 1,287 | $0 | 3/8/2023 | View on chart |
| ELUT | ▲ Buy | Open Market | 20,000 | $95K | 12/5/2022 | View on chart |
| ELUT | ▲ Buy | Open Market | 2,000 | $7K | 12/5/2022 | View on chart |
| ELUT | ▲ Buy | Open Market | 6,000 | $24K | 12/2/2022 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 13,874 | — | 9/8/2022 | View on chart |
| ELUT | ▼ Sell | Tax Withholding | 4,798 | $35K | 9/8/2022 | View on chart |
| ELUT | ▲ Buy | Option Exercise | 1,288 | $0 | 3/8/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Elutia Secures $8M from Boston Scientific, Funds Through 2029
Elutia announced it received an $8 million payment from Boston Scientific. This funding ensures the company is fully capitalized through 2029, removing near-term financial uncertainty. The news provides significant context for the stock's recent price action, as the company now has a clear runway for operations without immediate capital needs.
Elutia Secures $8M from Boston Scientific, Funds Through 2029. Elutia announced it received an $8 million payment from Boston Scientific. This funding ensures the company is fully capitalized through 2029, removing near-term financial uncertainty. The news provides significant context for the stock's recent price action, as the company now has a clear runway for operations without immediate capital needs.